Literature DB >> 10335796

Neurological complications in heparin-induced thrombocytopenia.

C Pohl, T Klockgether, A Greinacher, P Hanfland, U Harbrecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10335796     DOI： 10.1016/S0140-6736(99)01089-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Cerebral Venous Thrombosis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

2.  What's new about heparin-induced thrombocytopenia type II.

Authors:  Yasser Sakr
Journal:  Intensive Care Med       Date:  2015-04-23       Impact factor: 17.440

Review 3.  Heparin-induced thrombocytopenia and cerebral venous sinus thrombosis: case report and literature review.

Authors:  Mark J Fesler; Michael H Creer; John M Richart; Randall Edgell; Necat Havlioglu; Gershom Norfleet; Salvador Cruz-Flores
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 4.  Heparin-induced thrombocytopenia in the ICU: an overview.

Authors:  Yasser Sakr
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

5.  False-Negative Platelet Factor 4 Antibodies and Serotonin Release Assay and the Utility of Repeat Testing in the Diagnosis of Heparin-Induced Thrombocytopenia and Thrombosis.

Authors:  Tarig Omer; Naresh Mullaguri; Pravin George; Christopher R Newey
Journal:  Case Rep Hematol       Date:  2019-01-08

6.  Low ADAMTS-13 predicts adverse outcomes in hospitalized patients with suspected heparin-induced thrombocytopenia.

Authors:  Meng Chan; Xinyang Zhao; X Long Zheng
Journal:  Res Pract Thromb Haemost       Date:  2021-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.